Option Care Health, Inc.OPCH

NasdaqHealthcareServices-Home Health Care Services
Price (close)
$22.94
Market cap
$3.6B
P/E
17.5x
Revenue (TTM)
$5.7B
Net income
$206.2M
Dividend yield
—
1-year total return
-14.5%
Net margin
3.6%
Revenue growth
9.3%
Debt / equity
0.86x

What Option Care Health, Inc. does.

Option Care Health, Inc. (“Option Care Health”, “we”, “us”, “our”, or the “Company”) is the largest independent provider of home and alternate site infusion services through its national network of 196 locations in 43 states. Option Care Health draws on over 40 years of clinical care experience to offer patient-centered, cost-effective infusion therapy. Option Care Health’s infusion services include the clinical management of infusion therapy, nursing support and care coordination. Option Care Health’s multidisciplinary team of more than 5,000 clinicians, including pharmacists, pharmacy technicians, nurses and dietitians, are able to provide infusion service coverage for nearly all patients across the United States (“U.S.”) needing treatment for complex and chronic medical conditions.

On April 7, 2015, HC Group Holdings II, Inc. (“HC II”) and its sole shareholder, HC Group Holdings I, LLC. (“HC I”), collectively acquired Walgreens Infusion Services, Inc. and its subsidiaries from Walgreen Co., and the business was rebranded as Option Care, Inc. (“Option Care”).

On March 14, 2019, HC I and HC II entered into a definitive agreement to merge with and into a wholly-owned subsidiary of BioScrip, Inc. (“BioScrip”) (the “Merger”), a national provider of infusion and home care management solutions, which was completed on August 6, 2019 (the “Merger Date”). Following the close of the Merger, BioScrip was rebranded as Option Care Health, Inc.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$3.0B$3.4B$3.9B$4.3B$5.0B$5.6B
Net income-$8.1M$139.9M$150.6M$267.1M$211.8M$207.6M
Free cash flow$100.5M$182.9M$232.2M$329.4M$287.8M$217.1M

More on OPCH.

Figures from Option Care Health, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.